This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Epigenetic modification of mesenchymal stromal cells enhances their suppressive effects on the Th17 responses of cells from rheumatoid arthritis patients
Stem Cell Research & Therapy Open Access 09 August 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Becker MA and Jolly M (2006) Hyperuricemia and associated diseases. Rheum Dis Clin N Am 32: 275–293
Wallace KL et al. (2004) Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheum 31: 1582–1587
Gurwitz JH et al. (1997) Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol 50: 953–959
Fang J and Alderman M (2000) Serum uric acid and cardiovascular mortality: the NHANES1 Epidemiologic Follow-Up Study, 1971–1992. National Health and Nutrition Examination Survey. JAMA 283: 2404–2410
Janssens HJ et al. (2006) Gout, not induced by diuretics? A case–control study from primary care. Ann Rheum Dis 65: 1080–1083
Acknowledgements
The synopsis was written by Rachel Murphy, Assistant Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Professor MA Becker has declared that he is a consultant for TAP Pharmaceutical Products Inc, and on the Advisory Board for Savient Pharmaceuticals.
S Chohan declared she has no competing interests.
Rights and permissions
About this article
Cite this article
Chohan, S., Becker, M. Does diuretic use increase the risk of recurrent gout flares?. Nat Rev Rheumatol 2, 650–651 (2006). https://doi.org/10.1038/ncprheum0348
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0348